VectivBio
VectivBio is a Switzerland-based biotechnology company that researches and develops novel therapeutics for the treatment of rare diseases.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed VectivBio Information
VectivBio was acquired by
Ironwood Pharmaceuticals.
The acquisition happend on 2023-05-22.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Aeschenvorstadt 36
City: Basel
State: basel-city
Zip: 4051
Country: CH
Financial Info
Stage:
post ipo equity
Raised Last:
$125M
Raised Total:$399M
Social
Metrics
4,979,492Website Global Rank
1,894Website Monthly Traffic
Twitter Followers
Description
VectivBio is a Switzerland-based biotechnology company that researches and develops novel therapeutics for the treatment of rare diseases.
Contact Phone:
Contact Email:
VectivBio went public on 4/8/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/8/2021
IPO Valuation:
$578M
Ticker Symbol:
VECT
IPO Price:
$17/share
Amount Raised:
$128M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 8/2021 | Comet Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
